Proimmune has announced that its assay services for measuring cell mediated immune responses, including Elispot assays, are now available in accordance with GLP and GCP.
Assays for measuring cellular immune responses help address key questions in the development of biological therapies.
However, pharmaceutical companies often have difficulties integrating these assays into preclinical and clinical development processes while complying with GLP and GCP.
Outsourcing cellular assays to a dedicated facility working to GLP and GCP standards overcomes this problem, ensures data fully meets the requirements of regulatory submission and saves the cost and effort of setting up time-consuming assays in house.
